Viropharma, Inc. (VPHM) Balance Sheet

Click line-items for a historical chart and %

Assets
Cash and cash equivalents	205.59M
Short-term investments
Accounts receivable, net	61.48M
Inventory	100.12M
Prepaid expenses and other current assets	28.07M
Prepaid income taxes	16.88M
Deferred income taxes
Total current assets	494.63M
Intangible assets, net	489.58M
Property, equipment and building improvements, net	14.06M
Goodwill	96.8M
Debt issue costs, net
Deferred income taxes
Other assets	20.6M
Total assets	1.14B
Liabilities and Stockholders' Equity
Accounts payable	16.13M
Contingent consideration
Accrued expenses and other current liabilities
Income taxes payable	99K
Total current liabilities	91.79M
Other non-current liabilities	35K
Deferred tax liability	115.9M
Long-term debt
Total liabilities	408.29M
Stockholders' equity:
Preferred stock, par value $0.001 per share. 5,000,000 shares authorized; Series A convertible participating preferred stock; no shares issued and outstanding	0
Common stock, par value $0.002 per share. 175,000,000 shares authorized; issued and outstanding 75,893,066 shares at June 30, 2011 and 78,141,491 shares at December 31, 2010	164K
Treasury shares, at cost. 2,668,744 shares at June 30, 2011 and 0 shares at December 31, 2010	-350M
Additional paid-in capital	819.93M
Accumulated other comprehensive income (loss)	-3.1M
Retained earnings	260.92M
Total stockholders' equity	727.91M
Total liabilities and stockholders' equity	1.14B

Entities mentioned with VPHM